Skip to main content

Online Exclusive

The following is a transcript of the video Assessing Severity in Clinical Practice with Dawn M.R. Davis, MD.
The following is a transcript of the video Assessing Severity: Clinical and Quality of Life Indicators of Disease Severity with Dawn M.R. Davis, MD.
Melissa Weiss, Associate Editor
A recent cross-sectional study highlighted the reasons dermatologists were sanctioned by the Office of the Inspector General in the United States. In an interview with The Dermatologist, study authors Savannah Alvarado and Hao Feng, MD, discuss their findings and implications for clinical practice.
Melissa Weiss, Associate Editor
Tuberous sclerosis complex (TSC) is a rare, multiorgan, genetic disease with many cutaneous findings. In an interview with The Dermatologist, Elizabeth Thiele, MD, PhD, director of the TSC Center at Harvard Medical School, discusses common cutaneous symptoms of this disease.
Melissa Weiss, Associate Editor, Richard Fried, MD, PhD
While the United States is entering a new period of the COVID-19 pandemic, with some states reopening or relaxing lockdowns, there are still a lot of uncertainties and anxieties. In an interview for The Dermatologist, Richard Fried, MD, board-certified dermatologist and clinical psychologist, spoke with me about how dermatologists can care for their mental health during the COVID-19 pandemic.
April W. Armstrong, MD, MPH
It is important that we are nimble to use different models of teledermatology delivery, including live interactive and store-and-forward methods, and that we recognize that different patient populations may be receptive to different types of delivery.
Back to Top